Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 635

1.

Apocrine ductal carcinoma in situ of the breast: histologic classification and expression of biologic markers.

Leal C, Henrique R, Monteiro P, Lopes C, Bento MJ, De Sousa CP, Lopes P, Olson S, Silva MD, Page DL.

Hum Pathol. 2001 May;32(5):487-93.

PMID:
11381366
[PubMed - indexed for MEDLINE]
2.
3.

Biologic markers in ductal carcinoma in situ and concurrent infiltrating carcinoma. A comparison of eight contemporary grading systems.

Leong AS, Sormunen RT, Vinyuvat S, Hamdani RW, Suthipintawong C.

Am J Clin Pathol. 2001 May;115(5):709-18.

PMID:
11345835
[PubMed - indexed for MEDLINE]
Free Article
4.

Microinvasive ductal carcinoma (T1mic) of the breast. The clinicopathological profile and immunohistochemical features of 28 cases.

Yang M, Moriya T, Oguma M, De La Cruz C, Endoh M, Ishida T, Hirakawa H, Orita Y, Ohuchi N, Sasano H.

Pathol Int. 2003 Jul;53(7):422-8.

PMID:
12828606
[PubMed - indexed for MEDLINE]
5.

Tumour markers in breast carcinoma correlate with grade rather than with invasiveness.

Wärnberg F, Nordgren H, Bergkvist L, Holmberg L.

Br J Cancer. 2001 Sep 14;85(6):869-74.

PMID:
11556839
[PubMed - indexed for MEDLINE]
Free PMC Article
6.
7.

Immunohistochemical analysis on biological markers in ductal carcinoma in situ of the breast.

Iwase H, Ando Y, Ichihara S, Toyoshima S, Nakamura T, Karamatsu S, Ito Y, Yamashita H, Toyama T, Omoto Y, Fujii Y, Mitsuyama S, Kobayashi S.

Breast Cancer. 2001;8(2):98-104.

PMID:
11342981
[PubMed - indexed for MEDLINE]
8.

[Combined surgery and radiotherapy in the treatment of ductal carcinoma in situ of the breast: preliminary results of the Hungarian multicenter prospective randomised study].

Polgár C, Orosz Z, Kahán Z, Gábor G, Jani N, Cserni G, Hadijev J, Kulka J, Sulyok Z, Boross G, Lázár G, László Z, Diczházi C, Udvarhelyi N, Szabó E, Péntek Z, Major T, Fodor J.

Magy Onkol. 2008 Sep;52(3):269-77. doi: 10.1556/MOnkol.52.2008.3.4. Hungarian.

PMID:
18845497
[PubMed - indexed for MEDLINE]
9.

Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.

Khalifeh IM, Albarracin C, Diaz LK, Symmans FW, Edgerton ME, Hwang RF, Sneige N.

Am J Surg Pathol. 2008 Apr;32(4):544-52. doi: 10.1097/PAS.0b013e31815a87e2.

PMID:
18300793
[PubMed - indexed for MEDLINE]
10.

Oestrogen receptor negativity as a marker for high-grade ductal carcinoma in situ of the breast.

Baqai T, Shousha S.

Histopathology. 2003 May;42(5):440-7.

PMID:
12713620
[PubMed - indexed for MEDLINE]
11.

Ductal carcinoma in situ of the breast: correlation between histologic classifications and biologic markers.

Moreno A, Lloveras B, Figueras A, Escobedo A, Ramon JM, Sierra A, Fabra A.

Mod Pathol. 1997 Nov;10(11):1088-92.

PMID:
9388058
[PubMed - indexed for MEDLINE]
12.

Bax protein expression in DCIS of the breast in relation to invasive ductal carcinoma and other molecular markers.

Rehman S, Crow J, Revell PA.

Pathol Oncol Res. 2000;6(4):256-63.

PMID:
11173657
[PubMed - indexed for MEDLINE]
Free Article
13.

Breast carcinoma in women 35 years and younger: a pathological study.

Fernandopulle SM, Cher-Siangang P, Tan PH.

Pathology. 2006 Jun;38(3):219-22.

PMID:
16753742
[PubMed - indexed for MEDLINE]
14.

Loss of bcl-2 expression in ductal carcinoma in situ of the breast relates to poor histological differentiation and to expression of p53 and c-erbB-2 proteins.

Quinn CM, Ostrowski JL, Harkins L, Rice AJ, Loney DP.

Histopathology. 1998 Dec;33(6):531-6.

PMID:
9870147
[PubMed - indexed for MEDLINE]
15.

Basal phenotype of ductal carcinoma in situ: recognition and immunohistologic profile.

Dabbs DJ, Chivukula M, Carter G, Bhargava R.

Mod Pathol. 2006 Nov;19(11):1506-11. Epub 2006 Aug 25.

PMID:
16941011
[PubMed - indexed for MEDLINE]
Free Article
16.

p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer.

Barbareschi M, Leonardi E, Mauri FA, Serio G, Dalla Palma P.

Am J Clin Pathol. 1992 Oct;98(4):408-18.

PMID:
1357956
[PubMed - indexed for MEDLINE]
17.

Biological profile of in situ breast cancer investigated by immunohistochemical technique.

Albonico G, Querzoli P, Ferretti S, Rinaldi R, Nenci I.

Cancer Detect Prev. 1998;22(4):313-8.

PMID:
9674874
[PubMed - indexed for MEDLINE]
18.

Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.

Ottesen GL.

APMIS Suppl. 2003;(108):1-67. Review.

PMID:
12874968
[PubMed - indexed for MEDLINE]
19.

Are the pure in situ breast ductal carcinomas and those associated with invasive carcinoma the same?

Schorr MC, Pedrini JL, Savaris RF, Zettler CG.

Appl Immunohistochem Mol Morphol. 2010 Jan;18(1):51-4. doi: 10.1097/PAI.0b013e3181acaded.

PMID:
19568168
[PubMed - indexed for MEDLINE]
20.

Apoptosis in ductal carcinoma in situ of the breast.

Moreno A, Figueras A, Lloveras B, Escobedo A, Griera E, Sierra A, Fabra A.

Breast J. 2001 Jul-Aug;7(4):245-8.

PMID:
11678802
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk